Showing results (331-340 of 362) with videos related to
Sort By:
Pageof 37
Mbio|October 13, 2025
Single-cell analysis of human airway epithelium identifies cell-type-specific responses to <i>Aspergillus</i> and <i>Coccidioides</i>Alfred T Harding, Arianne J Crossen, Yanting Zhang, et al.JCI Insight|September 9, 2025
Virologic characteristics of SARS-CoV-2 infection across evolving Omicron subvariantsJulie Boucau, Owen T Glover, Caitlin Marino, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 23, 2022
Characterization of Virologic Rebound Following Nirmatrelvir-Ritonavir Treatment for Coronavirus Disease 2019 (COVID-19)Julie Boucau, Rockib Uddin, Caitlin Marino, et al.Open Forum Infectious Diseases|November 30, 2018
Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant <i>Pseudomonas aeruginosa</i> Infections: A Multicenter StudyJason C Gallagher, Michael J Satlin, Abdulrahman Elabor, et al.Mbio|May 14, 2020
Spleen Tyrosine Kinase Is a Critical Regulator of Neutrophil Responses to <i>Candida</i> SpeciesPaige E Negoro, Shuying Xu, Zeina Dagher, et al.Annals of Internal Medicine|November 13, 2023
SARS-CoV-2 Virologic Rebound With Nirmatrelvir-Ritonavir Therapy : An Observational StudyGregory E Edelstein, Julie Boucau, Rockib Uddin, et al.Medrxiv : the Preprint Server for Health Sciences|July 10, 2023
SARS-CoV-2 virologic rebound with nirmatrelvir-ritonavir therapyGregory E Edelstein, Julie Boucau, Rockib Uddin, et al.Cell Reports|June 23, 2015
Integrated Genomics of Crohn's Disease Risk Variant Identifies a Role for CLEC12A in Antibacterial AutophagyJakob Begun, Kara G Lassen, Humberto B Jijon, et al.Thyroid : Official Journal of the American Thyroid Association|April 3, 2018
Quantitative Analysis of the Benefits and Risk of Thyroid Nodule Evaluation in Patients ≥70 Years OldZhihong Wang, Chirag M Vyas, Olivia Van Benschoten, et al.Journal of Medicinal Chemistry|March 19, 2004
Design and synthesis of a fluoroindolocarbazole series as selective topoisomerase I active agents. Discovery of water-soluble 3,9-difluoro-12,13-dihydro-13-[6-amino-beta-D-glucopyranosyl]-5H,13H-benzo[b]- thienyl[2,3-a]pyrrolo[3,4-c]carbazole- 5,7(6H)-dione (BMS-251873) with curative antitumor activity against prostate carcinoma xenograft tumor modelBalu N Balasubramanian, Denis R St Laurent, Mark G Saulnier, et al.Pageof 37